NAPSA anticorps (C-Term)
Aperçu rapide pour NAPSA anticorps (C-Term) (ABIN2316367)
Antigène
Voir toutes NAPSA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 367-397, C-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- NAPSA, CT (NAPSA, NAP1, NAPA, Napsin-A, Aspartyl protease 4, Napsin-1, TA01/TA02)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- NAPSA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 367-397 amino acids from the C-terminal region of human NAPSA.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Autre désignation
- NAPSA
-
NCBI Accession
- NP_004842
-
UniProt
- O96009
-
Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Antigène
-